Net Cash Provided by (Used in) Financing Activities in USD of Vanda Pharmaceuticals Inc. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Vanda Pharmaceuticals Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • Vanda Pharmaceuticals Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$1.32M.
  • Vanda Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$155K.
  • Vanda Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $0.000, a 100% decline from 2022.
  • Vanda Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $734K, a 79.3% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Vanda Pharmaceuticals Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$1.32M -$1.32M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q1 2024 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q1 2022 $0 -$1.85M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-06
Q1 2021 $1.85M +$1.37M +286% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q1 2020 $479K +$300K +168% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $179K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2014 $2.01M +$2.2M Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-08
Q1 2013 -$193K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08

Vanda Pharmaceuticals Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$155K -$155K Jan 1, 2024 Dec 31, 2024 10-K 2025-02-14
2023 $0 -$734K -100% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-14
2022 $734K -$2.82M -79.3% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-14
2021 $3.55M -$2.08M -37% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-08
2020 $5.63M -$630K -10.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
2019 $6.26M -$101M -94.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $107M +$102M +1940% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 $5.25M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2013 $49.9M +$49.8M +415392% Jan 1, 2013 Dec 31, 2013 10-K 2014-02-25
2012 $12K -$13K -52% Jan 1, 2012 Dec 31, 2012 10-K 2014-02-25
2011 $25K -$3.76M -99.3% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-25
2010 $3.78M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.